Consensus Becton, Dickinson and Company

Stocks

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 07:00:03 17/10/26 am AEDT			5-day change	1st Jan Change
191.75 ^USD	-1.04%		+4.35%	-1.20%

08/10	Health Care Up on Defensive Bias -- Health Care Roundup	DJ
08/10	BD (Becton, Dickinson And Company) Announces Positive Nine-Month Results From The Iliac Cohort Of The AGILITY Investigational Device Exemption Trial Evaluating The Revello? Vascular Covered Stent	CI

Evolution of the Average Target: Becton, Dickinson and Company

Evolution of the Target Price: Becton, Dickinson and Company

Changes in Analyst Recommendations: Becton, Dickinson and Company

5be0f6128d797f0a7a673e480.GPpx5adYd8_IA6O9vVHceNSkYysZHGTYwMDko1wpx-M.WbUYkcBqE4jla-bp8xi3OaPjBmhvKzSR86qS7BlZsJNenB_W4wcxoIdr8g~d46dfcde00a9d10300f5b8ee634f9b92

Analysts' recommendations: Becton, Dickinson and Company

08/10	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $210 From $180	MT
07/10	Barclays Initiates Coverage on Becton, Dickinson and Company With Underweight Rating, $165 Price Target	MT
02/10	Argus Research Adjusts Becton, Dickinson and Company Price Target to $210 From $180, Maintains Buy Rating	MT
31/08	BofA Adjusts Price Target on Becton Dickinson and Co. to $200 From $185	MT
14/08	Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says	MT
13/08	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $208 From $204, Maintains Buy Rating	MT
13/08	RBC Adjusts PT on Becton Dickinson and Co. to $190 From $180, Keeps Sector Perform Rating	MT
12/08	UBS Adjusts Becton Dickinson and Co. PT to $205 From $190, Maintains Buy Rating	MT
08/08	Wells Fargo Adjusts Price Target on Becton Dickinson and Co. to $170 From $161	MT
08/08	Jefferies Adjusts Price Target on Becton Dickinson and Co. to $210 From $190	MT
08/08	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $204 From $198	MT
08/08	Piper Sandler Adjusts Price Target on Becton Dickinson and Co. to $175 From $161	MT
08/08	JPMorgan Adjusts Price Target on Becton Dickinson and Co. to $188 From $175	MT
07/08	RBC Adjusts PT on Becton Dickinson and Co. to $180 From $175, Maintains Sector Perform Rating	MT
06/08	TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $182 From $163	MT
29/07	UBS Initiates Coverage on Becton, Dickinson and Company With Buy Rating, $190 Price Target	MT
14/07	Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating	MT
09/07	Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says	MT
07/07	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $180 From $190	MT
12/06	BofA Adjusts Price Target on Becton, Dickinson and Company to $170 From $177	MT
27/05	Goldman Sachs Adjusts PT on Becton, Dickinson and Co. to $150 From $156, Maintains Neutral Rating	MT
09/05	Becton, Dickinson Building Growth After 'Clean' Fiscal Q2 Beat, RBC Says	MT
08/05	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $190 From $180	MT
08/05	Stifel Nicolaus Adjusts Becton, Dickinson and Company Price Target to $175 From $215	MT
04/05	TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $163 From $189, Maintains Hold Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	BECTON, DICKINSON AND COMPANY					+1.21%
	ABBOTT LABORATORIES					+15.09%
	MEDTRONIC PLC					+10.41%
	STRYKER CORPORATION					+23.06%
	ESSILORLUXOTTICA					+43.42%
	CENCORA, INC.					+7.85%
	HOYA CORPORATION					+16.96%
	IDEXX LABORATORIES, INC.					+25.9%
	DEXCOM, INC.					+12.11%
	ALCON INC.					+36.63%
	Average					+19.26%
	Weighted average by Cap.					+18.46%